NINGBO YUANFA BIOENGINEERING CO., LTD

Since its establishment in 2006, the company has been deeply engaged in the field of amino acids and their derivatives, focusing on product research and development and production, including L-glutamic acid, L-glutamate hydrochloride, L-arginine hydrochloride, L-cysteine, N-acetylcysteine, etc. With professional technical strength and excellent product quality, it has established a good reputation in the industry. The company's factory covers an area of 27 acres and has a building area of 36,000 square meters, with a total investment of 160 million yuan. Modern production equipment and advanced process flow complement each other, forming a complete production system. Relying on strong production capacity support, the company's annual production of amino acid products is nearly 10,000 tons, of which 80% of the products are exported to countries and regions such as Europe, America, and Southeast Asia. Not only are they popular in developed economies, but they also occupy an important share in the booming emerging markets. In diverse application fields, the company's products deeply integrate into core industries such as biomedicine, pharmaceutical intermediates, health and nutrition products, and food additives. Especially in the L-arginine hydrochloride niche market, it performs outstandingly, occupying important market shares in both domestic and international markets as a benchmark product in the industry. At the same time, a research team led by a German returned bio-nutritionology doctor and jointly formed with top industry experts in China has been continuously deepening high value-added technology fields, successfully launching high-end and fine amino acid nutritional active agent series products. This series has risen to become the company's core competitiveness. Looking at the present and looking forward to the future, Chenrun New Materials will take "Leading biotechnology and empowering the future of health" as its mission, continuously deepen collaborative innovation between industry, academia, and research, and accelerate the construction of a globally competitive leading enterprise in biotechnology new materials with R&D, production, and service integration.